1 – 10 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
EMAS position statement: The ten point guide to the integral management of menopausal health.
(
- Contribution to journal › Article
- 2014
-
Mark
Use of proton pump inhibitors (PPI) and history of earlier fracture are independent risk factors for fracture in postmenopausal women. The WHILA study.
(
- Contribution to journal › Article
- 2013
-
Mark
Low androstenedione/sex hormone binding globulin ratio increases fracture risk in postmenopausal women. The Women's Health in the Lund Area study.
(
- Contribution to journal › Article
-
Mark
Low BMD is an independent predictor of fracture and early menopause of mortality in post-menopausal women - A 34-year prospective study.
(
- Contribution to journal › Article
- 2011
-
Mark
Hormone therapy and coronary heart disease risk by vasomotor menopausal symptoms.
(
- Contribution to journal › Article
- 2010
-
Mark
Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women.
(
- Contribution to journal › Article
-
Mark
The Women's Health in the Lund Area (WHILA) study-An overview.
(
- Contribution to journal › Article
- 2008
-
Mark
A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density.
(
- Contribution to journal › Article
- 2007
-
Mark
One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women.
(
- Contribution to journal › Article
- 2006
-
Mark
The effect of continuous HRT on glucose homeostasis and plasma lipids. A placebo-controlled study in postmenopausal women with type 2 diab
(
- Contribution to journal › Article